BBNX
Beta Bionics, Inc. Common Stock
NASDAQ: BBNX · HEALTHCARE · MEDICAL DEVICES
$9.90
-1.79% today
Updated 2026-04-29
Market cap
$441.16M
P/E ratio
—
P/S ratio
4.00x
EPS (TTM)
$-1.37
Dividend yield
—
52W range
$9 – $33
Volume
1.2M
Beta Bionics, Inc. Common Stock (BBNX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-60.30%
Operating margin
-87.90%
ROE
-22.70%
ROA
-15.00%
Debt/equity
0.04x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $179000.00 | $-64.75M | 100.00% | -36,784.36% | -36,173.74% |
| 2023 | $11.99M | $-44.10M | 52.59% | -298.87% | -367.64% |
| 2024 | $65.12M | $-54.76M | 55.11% | -69.48% | -84.08% |
| 2025 | $100.25M | $-73.20M | 55.40% | -71.50% | -73.02% |